Comparison of commercially-available preservatives for maintaining the integrity of bacterial DNA in human milk

被引:17
|
作者
Lackey, Kimberly A. [1 ]
Williams, Janet E. [2 ]
Price, William J. [3 ]
Carrothers, Janae M. [1 ]
Brooker, Sarah L. [2 ,4 ]
Shafii, Bahman [3 ]
McGuire, Mark A. [2 ]
McGuire, Michelle K. [1 ,5 ]
机构
[1] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA
[2] Univ Idaho, Dept & Anim & Vet Sci, Moscow, ID 83843 USA
[3] Univ Idaho, Stat Programs, Moscow, ID 83843 USA
[4] Univ Idaho, Dept Biol Sci, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA
[5] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA
基金
美国国家科学基金会;
关键词
Bacteria; Human milk; Lactation; Methods; Microbiome; Preservation; HEALTHY WOMEN; BREAST-MILK; STORAGE; SAMPLES; MICROBIOME; PCR; RNA; DIVERSITY;
D O I
10.1016/j.mimet.2017.08.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Inhibiting changes to bacteria in human milk between sample collection and analysis is necessary for unbiased characterization of the milk microbiome. Although cold storage is considered optimal, alternative preservation is sometimes necessary. Research aim/question: The objective of this study was to compare the effectiveness of several commercially available preservatives with regard to maintaining bacterial DNA in human milk for delayed microbiome analysis. Specifically, we compared Life Technologies' RNAlater (R) stabilization solution, Biomatrica's DNAgard (R) Saliva, Advanced Instruments' Broad Spectrum Microtabs II (TM), and Norgen Biotek Corporation's Milk DNA Preservation and Isolation Kit. Methods: Aliquots of 8 pools of human milk were treated with each preservative. DNA was extracted immediately and at 1, 2, 4, and 6 wk, during which time milk was held at 37 degrees C. The V1-V3 region of the bacterial 16S rRNA gene was amplified and sequenced. Changes in bacterial community structure and diversity over time were evaluated. Results: Comparable to other studies, the most abundant genera were Streptococcus (33.3%), Staphylococcus (14.0%), Dyella (6.3%), Pseudomonas (3.0%), Veillonella (2.5%), Hafnia (2.0%), Prevotella (1.7%), Rhodococcus (1.6%), and Granulicatella (1.4%). Overall, use of Norgen's Milk DNA Preservation and Isolation Kit best maintained the consistency of the bacterial community structure. Total DNA, diversity, and evenness metrics were also highest in samples preserved with this method. Conclusions: When collecting human milk for bacterial community analysis in field conditions where cold storage is not available, our results suggest that Norgen's Milk DNA Preservation and Isolation Kit may be a useful method, at least for a period of 2 weeks.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 50 条
  • [21] Comparison of Two Commercially Available Liquid Human Milk Fortifiers for Feeding Tolerance in Premature Infants
    Calma, Eleanor
    Judkins, Allison
    Truong, Giang
    Kadri, Munaf
    Phillips, Raylene
    PEDIATRICS, 2018, 141
  • [22] HOW APPROPRIATE ARE COMMERCIALLY AVAILABLE HUMAN-MILK FORTIFIERS
    METCALF, R
    DILENA, B
    GIBSON, R
    MARSHALL, P
    SIMMER, K
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1994, 30 (04) : 350 - 355
  • [23] Evaluation of commercially available preservatives for laboratory detection of helminths and protozoa in human fecal specimens
    Pietrzak-Johnston, SM
    Bishop, H
    Wahlquist, S
    Moura, H
    Da Silva, ND
    Da Silva, SP
    Nguyen-Dinh, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) : 1959 - 1964
  • [24] Sustainable Materials for Transportation Infrastructures: Comparison of Three Commercially-Available Metakaolin Products in Binary Cementitious Systems
    Sullivan, Matthew S.
    Chorzepa, Mi G.
    Hamid, Hiwa
    Durham, Stephan A.
    Kim, S. Sonny
    INFRASTRUCTURES, 2018, 3 (03)
  • [25] The measurement of human motion: A comparison of commercially available systems
    Richards, JG
    HUMAN MOVEMENT SCIENCE, 1999, 18 (05) : 589 - 602
  • [26] Consumption of commercially-available polyphenolic supplement for 7 days inhibits platelet aggregation in healthy human subjects
    Shanmuganayagam, D
    Folts, JD
    FASEB JOURNAL, 2005, 19 (04): : A452 - A452
  • [27] Validation of current commercially-available devices to thaw pooled, solvent/detergent-treated human plasma
    Heger, Andrea
    Gareis, Michelle
    TRANSFUSION MEDICINE, 2025, 35 (01) : 97 - 102
  • [28] Comparison of Vendor-Dependent Versus Commercially-Available, Independent LINAC Quality Assurance (QA) for Daily QA
    Stambaugh, C.
    Melhus, C.
    MEDICAL PHYSICS, 2020, 47 (06) : E730 - E730
  • [29] A comparison of commercially-available automated and manual extraction kits for the isolation of total RNA from small tissue samples
    Marlo K Sellin Jeffries
    Andor J Kiss
    Austin W Smith
    James T Oris
    BMC Biotechnology, 14
  • [30] Comparison of clinical knowledge management capabilities of commercially-available and leading internally-developed electronic health records
    Dean F Sittig
    Adam Wright
    Seth Meltzer
    Linas Simonaitis
    R Scott Evans
    W Paul Nichol
    Joan S Ash
    Blackford Middleton
    BMC Medical Informatics and Decision Making, 11